Artemis 2 NASA astronaut Reid Wiseman who commanded the first moon mission in half a century talks to Space.com about the parallels between the two moon efforts. The 55th anniversary of Apollo 8's ...

The FDA’s breakthrough therapy designation for GSK’227 underscores its potential to address the critical unmet needs of ...

American Coastal Insurance Company (AmCoastal) has successfully renewed its all other perils reinsurance arrangement for 2025 ...

An ambitious project to launch the first cellular network on the Moon is moving closer to reality. Nokia Bell Labs and Intuitive Machines, Inc. announced that the final integration of Nokia’s Lunar ...

US company Firefly Aerospace said Tuesday it is aiming to launch a lander to the moon next week under an experimental NASA ...

NEAR Protocol shows signs of bearish momentum, with declining active addresses and technical indicators pointing to a ...

GSK5764227 (HS-20093) is a novel antibody-drug conjugate composed of a fully human anti-B7-H3 monoclonal antibody covalently linked to a topoisomerase inhibitor payload.

Grayscale and Artemis classify XRP as a store of value, highlighting its hard-capped supply and utility for cross-border ...

The ASX keeps charging, while Wall Street slips on strong US data and Energy Transition Minerals pops on Trump's Greenland ...

Bechtel has lifted and placed the first tower module of NASA ’s Mobile Launcher 2, or ML2, at Kennedy Space Center, paving ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GSK5764227 (GSK’227) for the treatment of adult patients with relapsed or refractory (R/R) osteosarcoma who have ...

In a report released today, Stephen Soock from Stifel Nicolaus maintained a Buy rating on Vizsla Silver (VZLA – Research Report), with a price ...